Skip to main content Start of content

HESA Committee Meeting

Notices of Meeting include information about the subject matter to be examined by the committee and date, time and place of the meeting, as well as a list of any witnesses scheduled to appear. The Evidence is the edited and revised transcript of what is said before a committee. The Minutes of Proceedings are the official record of the business conducted by the committee at a sitting.

For an advanced search, use Publication Search tool.

If you have any questions or comments regarding the accessibility of this publication, please contact us at accessible@parl.gc.ca.

Previous day publication Next day publication

Minutes of Proceedings

42nd Parliament, 1st Session
Meeting No. 33
Tuesday, November 29, 2016, 8:46 a.m. to 10:36 a.m.
Presiding
Bill Casey, Chair (Liberal)

Library of Parliament
• Karin Phillips, Analyst
Arthritis Society
• Janet Yale, President and Chief Executive Officer
Canadian Federation of Nurses Unions
• Linda Silas, President
• Anil Naidoo, Government Relations Officer
University of British Columbia Therapeutics Initiative
• Thomas L. Perry, Chair, Education Working Group
As an individual
• Doug Coyle, Professor and Interim Director, University of Ottawa, School of Epidemiology, Public Health and Preventive Medicine
Pursuant to Standing Order 108(2) and the motion adopted by the Committee on March 7, 2016, the Committee resumed its study of the Development of a National Pharmacare Program.

Thomas L. Perry, Janet Yale, Linda Silas and Doug Coyle made statements and, with Anil Naidoo, answered questions.

By unanimous consent, it was agreed, — That, notwithstanding the Committee routine motion on the distribution of documents, adopted on Monday, February 3, 2016, the Clerk be authorized to distribute reference documents in English only.

The Committee proceeded to the consideration of matters related to Committee business.

Motion

Colin Carrie moved, — That, pursuant to Standing Order 108(1), the Committee call upon the Minister of Health to immediately appear as a witness to discuss the opioid summit and the next steps in dealing with this serious crisis.

Motion

John Oliver moved, — That the debate be now adjourned.

The question was put on the motion and it was agreed to, by a show of hands: YEAS: 6; NAYS: 2.

Arthritis Society
• Janet Yale, President and Chief Executive Officer
Canadian Federation of Nurses Unions
• Linda Silas, President
• Anil Naidoo, Government Relations Officer
University of British Columbia Therapeutics Initiative
• Thomas L. Perry, Chair, Education Working Group
As an individual
• Doug Coyle, Professor and Interim Director, University of Ottawa, School of Epidemiology, Public Health and Preventive Medicine
Pursuant to Standing Order 108(2) and the motion adopted by the Committee on March 7, 2016, the Committee resumed its study of the Development of a National Pharmacare Program.

Questioning of the witnesses resumed.
The Committee proceeded to the consideration of matters related to Committee business.

The Committee resumed consideration of the motion of Colin Carrie, which read as follows:

That, pursuant to Standing Order 108(1), the Committee call upon the Minister of Health to immediately appear as a witness to discuss the opioid summit and the next steps in dealing with this serious crisis.

The question was put on the motion and it was agreed to, by a show of hands: YEAS: 9; NAYS: 0.

At 10:36 a.m., the Committee adjourned to the call of the Chair.



David Gagnon
Clerk of the Committee